By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    photo of hands with blue veins
    8 Proven Tips on Finding Difficult Veins
    November 12, 2021
    tips for getting over the pandemic blues
    4 Proven Ways to Get Over the Pandemic Blues
    February 22, 2022
    medical industry innovations
    How is CNC Machining Transforming the Medical Industry?
    June 2, 2022
    Latest News
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
    The Hidden Impact Of Stress On Your Body’s Alignment And Balance
    May 22, 2025
    Chewing Matters More Than You Think: Why Proper Chewing Supports Better Health
    May 22, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Transformational and Disruptive Changes Are Coming to the Delivery System
    July 22, 2012
    Telemedicine and the PCP Cliff
    November 30, 2012
    Engaging Specialty Practices in the Patient Centered Medical Neighborhood
    March 24, 2013
    Latest News
    Streamlining Healthcare Operations: How Our Consultants Drive Efficiency and Overall Improvement
    June 11, 2025
    Building Smarter Care Teams: Aligning Roles, Structure, and Clinical Expertise
    May 18, 2025
    The Critical Role of Healthcare in Personal Injury Recovery: A Comprehensive Guide for Victims
    May 14, 2025
    The Backbone of Successful Trials: Clinical Data Management
    April 28, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: New Blood Test Could Help Doctors Figure Out Origins of Strokes
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Technology > Medical Innovations > New Blood Test Could Help Doctors Figure Out Origins of Strokes
DiagnosticsMedical InnovationsSpecialties

New Blood Test Could Help Doctors Figure Out Origins of Strokes

Deanna Pogorelc
Last updated: January 27, 2014 9:00 am
Deanna Pogorelc
Share
4 Min Read
SHARE

blood testFirst published on MedCityNews.com. Clinical trials are underway for what could be a first-of-its-kind blood test that would help doctors determine what caused a patient to have a stroke.

blood testFirst published on MedCityNews.com. Clinical trials are underway for what could be a first-of-its-kind blood test that would help doctors determine what caused a patient to have a stroke.

Developed by Cincinnati-based Ischemia Care, the test isolates RNA from whole blood and examines immune responses, with the goal of differentiating where an ischemic stroke originated in a patient’s body.

Stroke is normally diagnosed through physical examinations and diagnostic imaging. But in about one-third of cases, doctors aren’t able to identify a cause. Being able to determine whether the stroke originated in the heart or in the blood vessels could have a huge impact on how patients are treated and on preventing recurrent strokes, said CEO Jeff June. About a quarter of the 800,000 Americans who have a stroke each year will go on to have another one, which carries a higher risk of death and disability.

More Read

Cannabis is Excellent for Taking the Edge off Dual Anxiety and Depressive Disorders
Where There Is Research, There Is Hope
Improving Care Coordination for Aging New Yorkers
Patient Centered Medical Homes: What it Takes for PCMH Accreditation
Lung Cancer Overview – Part 1 of 5

The idea behind Ischemia Care’s test, ISCDX, is that a physician would order it for patients who present with stoke symptoms. They would draw a vial of blood, send it to the company’s CLIA-certified lab and expect results within four to five days. That’s a critical time frame because most patients who have a stroke are hospitalized for five to 12 days, June said, so if physicians know what caused the stroke within that time frame, they can get a patient started with the proper treatment regimen before leaving the hospital.

“We have a much better understanding of the market and the uptake,” June said, recalling the last time he talked to MedCity News about the company nearly two years ago. “Before, we looked at ischemic stroke and could discern between originating in the heart and blood vessels. Now we also look at patients who come in the door with suspected stroke, a transient ischemic attack or some perceived neurological deficit.”

Another important feature the company has added to its test is the ability to differentiate between ischemic strokes that originate in the heart and are caused by atrial fibrillation, and those that originate in the heart but aren’t caused by AF.

“This is often missed in early clinical assessment of patients because many times when patients are evaluated for stroke, they’re not in A-fib,” June said.

While there are other blood tests that physicians use to determine whether a patient has had a stroke, June said this is the first technology he’s aware of that looks for immune markers. It’s being evaluated in a 600-patient clinical trial already underway at Cleveland Clinic and The Medical University of South Carolina, with plans to bring three other sites onto the study, he said. He’s hoping to have results by the third quarter of this year.

Ischemia Care is focusing its early efforts toward clinical adoption on the nearly 800 U.S. hospitals designated as Primary Stroke Centers. Although it’s taking the CLIA-lab approach initially, June said the long-term strategy involves a blood test that could be done at the point of care.

Ischemia Care, founded in 2009, has designed the study and the test with help from partners including Medtronic and Affymetrix. It’s been financed both by grants and by investors — most recently a $1.1 million round led by Cincinnati’s Queen City Angels. June said the company is actively looking for a corporate partner or for Series A investors.

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Streamlining Healthcare Operations: How Our Consultants Drive Efficiency and Overall Improvement
Global Healthcare Policy & Law
June 11, 2025
magnesium supplements
The Wide-Ranging Benefits of Magnesium Supplements
Health
June 11, 2025
Preparing for the Next Pandemic: How Technology is Changing the Game
Technology
June 6, 2025
migraine home remedies and-devices
The Best Home Remedies for Migraines
Health Mental Health
June 5, 2025

You Might also Like

Physicians Too Aggressive in Ordering Prostate Screenings

May 17, 2011
pollen allergies
AllergySpecialties

Pollen 101: Everything You Need to Know About This Common Allergy Trigger

February 24, 2021

Pill Bottle Warnings Go Unnoticed

September 11, 2012

Wi-Fi Alliance® and Continua® Health Alliance Collaborate on Personal Connected Health

February 22, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?